293 related articles for article (PubMed ID: 12577410)
1. [Radioiodine treatment of differentiated thyroid carcinomas: residual ablation].
Konrády A
Orv Hetil; 2002 Jun; 143(25):1557; author reply. PubMed ID: 12577410
[No Abstract] [Full Text] [Related]
2. [Radioiodine therapy in differentiated thyroid gland carcinoma].
Schicha H; Dietlein M
Zentralbl Chir; 1997; 122(4):266-73. PubMed ID: 9221637
[TBL] [Abstract][Full Text] [Related]
3. The continuous debate in literature about the usage of iodine-131 dosing for the ablation of thyroid remnants and metastases.
De Klerk JM; Oyen WJ
Minerva Endocrinol; 2009 Mar; 34(1):57-69. PubMed ID: 19209128
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].
Lind P; Igerc I; Kohlfürst S
Wien Med Wochenschr; 2005 Oct; 155(19-20):429-35. PubMed ID: 16424998
[TBL] [Abstract][Full Text] [Related]
5. Differentiated thyroid carcinoma in children and adolescents: clinical course and therapeutic approach.
Pazaitou-Panayiotou K
Pediatr Endocrinol Rev; 2004 Aug; 1 Suppl 3():508-12. PubMed ID: 16444184
[TBL] [Abstract][Full Text] [Related]
6. Radioiodine therapy in differentiated thyroid carcinoma.
Salvatori M; Rufini V; Garganese MC; Di Giuda D
Rays; 2000; 25(2):221-38. PubMed ID: 11370540
[TBL] [Abstract][Full Text] [Related]
7. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation.
Azrif M; Slevin NJ; Sykes AJ; Swindell R; Yap BK
Radiother Oncol; 2008 Oct; 89(1):105-13. PubMed ID: 18579244
[TBL] [Abstract][Full Text] [Related]
8. Low- or high-dose radioiodine remnant ablation for differentiated thyroid carcinoma: a meta-analysis.
Cheng W; Ma C; Fu H; Li J; Chen S; Wu S; Wang H
J Clin Endocrinol Metab; 2013 Apr; 98(4):1353-60. PubMed ID: 23436920
[TBL] [Abstract][Full Text] [Related]
9. [Is radioiodine ablation of residual thyroid tissue indicated after an operation for differentiated thyroid cancer?].
Chebotareva ED; Shishkina VV
Lik Sprava; 1997; (1):118-22. PubMed ID: 9221132
[No Abstract] [Full Text] [Related]
10. Treatment of "locally advanced" well-differentiated thyroid carcinomas.
Falvo L; Catania A; Grilli P; Di Matteo FM; De Antoni E
Ann Ital Chir; 2004; 75(1):17-21. PubMed ID: 15283382
[TBL] [Abstract][Full Text] [Related]
11. Role of radioiodine in management of thyroid cancer: experience with 70 cases.
Afroz S; Ahmed K; Yasmeen S; Ahmed F; Nisa L
Bangladesh Med Res Counc Bull; 1992 Dec; 18(2):68-71. PubMed ID: 1303083
[TBL] [Abstract][Full Text] [Related]
12. A prospective clinical trial to assess the efficacy of radioiodine ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer undergoing sub-total thyroidectomy.
Bal CS; Kumar A; Chandra P; Dwivedi SN; Pant GS
Acta Oncol; 2006; 45(8):1067-72. PubMed ID: 17118841
[TBL] [Abstract][Full Text] [Related]
13. Is radioiodine ablation necessary for patients with low-risk papillary thyroid carcinoma and tumor >4 cm?
Rosario PW
Eur J Surg Oncol; 2017 Sep; 43(9):1802-1803. PubMed ID: 28743373
[No Abstract] [Full Text] [Related]
14. [Differentiated thyroid carcinoma in children and adolescents: therapeutic strategy according to clinic presentation].
Causeret S; Lifante JC; Borson-Chazot F; Varcus F; Berger N; Peix JL
Ann Chir; 2004; 129(6-7):359-64. PubMed ID: 15297226
[TBL] [Abstract][Full Text] [Related]
15. Radioiodine-remnant ablation in low-risk differentiated thyroid cancer: pros.
Ain KB
Endocrine; 2015 Sep; 50(1):61-6. PubMed ID: 26109472
[TBL] [Abstract][Full Text] [Related]
16. Cumulative doses of adjunct 131I treatment depend on location of residual thyroid tissue after total thyroidectomy in differentiated thyroid cancer.
Saint-Vil D; Emran MA; Lambert R; Alos N; Turpin S; Huot C
J Pediatr Surg; 2007 May; 42(5):853-6. PubMed ID: 17502198
[TBL] [Abstract][Full Text] [Related]
17. The evolving role of (131)I for the treatment of differentiated thyroid carcinoma.
Robbins RJ; Schlumberger MJ
J Nucl Med; 2005 Jan; 46 Suppl 1():28S-37S. PubMed ID: 15653649
[TBL] [Abstract][Full Text] [Related]
18. Incidence of radiation thyroiditis and thyroid remnant ablation success rates following 1110 MBq (30 mCi) and 3700 MBq (100 mCi) post-surgical 131I ablation therapy for differentiated thyroid carcinoma.
Cherk MH; Kalff V; Yap KS; Bailey M; Topliss D; Kelly MJ
Clin Endocrinol (Oxf); 2008 Dec; 69(6):957-62. PubMed ID: 18419785
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of poorly differentiated thyroid carcinomas compared with those of classical papillary thyroid carcinomas.
Lin JD; Chao TC; Hsueh C
Clin Endocrinol (Oxf); 2007 Feb; 66(2):224-8. PubMed ID: 17223992
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant treatment of thyroid cancer.
Beauduin M; Hermans J; Majois F
Acta Otorhinolaryngol Belg; 1987; 41(5):944-5. PubMed ID: 3454107
[No Abstract] [Full Text] [Related]
[Next] [New Search]